<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Book Authors/John Carreyrou on paapereira.xyz</title><link>https://paapereira.xyz/book-authors/john-carreyrou/</link><description>Recent content in Book Authors/John Carreyrou on paapereira.xyz</description><generator>Hugo</generator><language>en-US</language><copyright>&lt;a href='https://creativecommons.org/licenses/by-nc/4.0/' target='_blank' rel='noopener'>©&lt;/a> 2008-2026 / &lt;a href='https://gitlab.com/paapereira/paapereira.gitlab.io' target='_blank' rel='noopener'>source code&lt;/a></copyright><lastBuildDate>Sun, 27 Jan 2019 18:15:00 +0000</lastBuildDate><atom:link href="https://paapereira.xyz/book-authors/john-carreyrou/index.xml" rel="self" type="application/rss+xml"/><item><title>Bad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou (2018)</title><link>https://paapereira.xyz/books/bad-blood/</link><pubDate>Sun, 27 Jan 2019 18:15:00 +0000</pubDate><guid>https://paapereira.xyz/books/bad-blood/</guid><description>&lt;h3 id="bad-blood-secrets-and-lies-in-a-silicon-valley-startup-by-john-carreyrou-2018">Bad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou (2018)&lt;/h3>
&lt;p>&lt;img src="https://paapereira.xyz/reads/bad-blood.jpg" alt="cover">&lt;/p>
&lt;ul>
&lt;li>Author: &lt;a href="https://paapereira.xyz/book-authors/john-carreyrou">John Carreyrou&lt;/a>&lt;/li>
&lt;li>First Published: &lt;a href="https://paapereira.xyz/book-publication-year/2018">May 21st 2018&lt;/a>&lt;/li>
&lt;li>Score: &lt;a href="https://paapereira.xyz/book-scores/7/10-books">7/10&lt;/a>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>&lt;a href="https://www.goodreads.com/book/show/40217960-bad-blood">Goodreads&lt;/a>&lt;/p>
&lt;p>The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers.&lt;/p>
&lt;p>In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup &amp;ldquo;unicorn&amp;rdquo; promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes&amp;rsquo;s worth at an estimated $4.7 billion. There was just one problem: The technology didn&amp;rsquo;t work.&lt;/p></description></item></channel></rss>